2024-05-15 |
2024-05-15 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
1.000
-1.5%
3,66
100.000
USD
|
1.000
-1.5%
|
3,66
|
100.000
USD
|
|
2024-05-15 |
2024-05-14 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
1.000
-1.3%
3,58
100.000
USD
|
1.000
-1.3%
|
3,58
|
100.000
USD
|
|
2024-05-15 |
2024-05-13 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
1.000
-0.3%
3,62
100.000
USD
|
1.000
-0.3%
|
3,62
|
100.000
USD
|
|
2024-05-09 |
2024-05-08 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
1.000
-1.2%
3,82
100.000
USD
|
1.000
-1.2%
|
3,82
|
100.000
USD
|
|
2024-05-09 |
2024-05-07 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
1.000
-0.5%
3,67
100.000
USD
|
1.000
-0.5%
|
3,67
|
100.000
USD
|
|
2024-05-01 |
2024-05-01 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
33.061
-2.7%
3,30
109.161
USD
|
33.061
-2.7%
|
3,30
|
109.161
USD
|
|
2024-05-01 |
2024-04-30 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
20.535
-1.6%
3,12
63.981
USD
|
20.535
-1.6%
|
3,12
|
63.981
USD
|
|
2024-05-01 |
2024-04-29 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
6.403
-0.5%
3,25
20.792
USD
|
6.403
-0.5%
|
3,25
|
20.792
USD
|
|
2024-04-24 |
2024-04-24 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
8.064
-0.6%
3,50
28.251
USD
|
8.064
-0.6%
|
3,50
|
28.251
USD
|
|
2024-04-24 |
2024-04-23 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
22.000
-1.7%
3,49
76.800
USD
|
22.000
-1.7%
|
3,49
|
76.800
USD
|
|
2024-04-24 |
2024-04-22 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
14.331
-1.1%
3,53
50.597
USD
|
14.331
-1.1%
|
3,53
|
50.597
USD
|
|
2024-04-18 |
2024-04-17 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
22.737
-1.7%
3,71
84.425
USD
|
22.737
-1.7%
|
3,71
|
84.425
USD
|
|
2024-04-18 |
2024-04-16 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
48.683
-3.5%
3,53
171.802
USD
|
48.683
-3.5%
|
3,53
|
171.802
USD
|
|
2023-12-18 |
2023-12-15 |
V
Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
5.803
-100.0%
14,18
82.265
USD
|
5.803
-100.0%
|
14,18
|
82.265
USD
|
|
2023-12-18 |
2023-12-15 |
V
Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
26.732
-82.2%
12,94
345.915
USD
|
26.732
-82.2%
|
12,94
|
345.915
USD
|
|
2023-12-14 |
2023-12-13 |
V
Verkauf
|
Thomas John
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.927
-0.4%
13,93
26.839
USD
|
1.927
-0.4%
|
13,93
|
26.839
USD
|
|
2023-12-14 |
2023-12-13 |
V
Verkauf
|
Thomas John
Nicht geschäftsführender Verwaltungsratsmitglied
|
7.073
-1.5%
13,23
93.548
USD
|
7.073
-1.5%
|
13,23
|
93.548
USD
|
|
2023-12-14 |
2023-12-13 |
V
Verkauf
|
Tyree James L
Nicht geschäftsführender Verwaltungsratsmitglied
|
3.347
-49.2%
13,73
45.963
USD
|
3.347
-49.2%
|
13,73
|
45.963
USD
|
|
2023-12-14 |
2023-12-13 |
V
Verkauf
|
Tyree James L
Nicht geschäftsführender Verwaltungsratsmitglied
|
5.653
-45.4%
12,91
73.006
USD
|
5.653
-45.4%
|
12,91
|
73.006
USD
|
|
2023-12-08 |
2023-12-07 |
V
Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
36.800
-53.1%
11,85
435.995
USD
|
36.800
-53.1%
|
11,85
|
435.995
USD
|
|
2023-11-22 |
2023-11-21 |
V
Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
18.665
-21.2%
10,26
191.555
USD
|
18.665
-21.2%
|
10,26
|
191.555
USD
|
|
2023-11-21 |
2023-11-20 |
V
Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
14.594
-14.2%
11,26
164.261
USD
|
14.594
-14.2%
|
11,26
|
164.261
USD
|
|
2023-11-21 |
2023-11-17 |
V
Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
3.541
-3.3%
13,04
46.170
USD
|
3.541
-3.3%
|
13,04
|
46.170
USD
|
|
2023-10-26 |
2023-10-25 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
5.704
-0.4%
19,40
110.638
USD
|
5.704
-0.4%
|
19,40
|
110.638
USD
|
|
2023-10-25 |
2023-10-24 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
5.200
-4.7%
19,11
99.351
USD
|
5.200
-4.7%
|
19,11
|
99.351
USD
|
|
2023-10-25 |
2023-10-23 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
49.987
-3.5%
19,97
998.365
USD
|
49.987
-3.5%
|
19,97
|
998.365
USD
|
|
2023-10-16 |
2023-10-16 |
GV
Geplanter Verkauf
|
Thomas John
Nicht geschäftsführender Verwaltungsratsmitglied
|
881
-0.2%
21,30
18.769
USD
|
881
-0.2%
|
21,30
|
18.769
USD
|
|
2023-10-16 |
2023-10-16 |
GV
Geplanter Verkauf
|
Thomas John
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.452
-0.5%
20,50
50.269
USD
|
2.452
-0.5%
|
20,50
|
50.269
USD
|
|
2023-10-11 |
2023-10-10 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
400
-0.4%
22,91
9.162
USD
|
400
-0.4%
|
22,91
|
9.162
USD
|
|
2023-10-11 |
2023-10-10 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
4.800
-4.3%
21,94
105.300
USD
|
4.800
-4.3%
|
21,94
|
105.300
USD
|
|
2023-10-10 |
2023-10-05 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
985
-0.1%
25,47
25.090
USD
|
985
-0.1%
|
25,47
|
25.090
USD
|
|
2023-10-10 |
2023-10-05 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
13.266
-0.9%
24,89
330.139
USD
|
13.266
-0.9%
|
24,89
|
330.139
USD
|
|
2023-10-04 |
2023-10-03 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
75.690
-5.0%
25,49
1.929.225
USD
|
75.690
-5.0%
|
25,49
|
1.929.225
USD
|
|
2023-09-29 |
2023-09-28 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
2.289
-0.2%
24,12
55.211
USD
|
2.289
-0.2%
|
24,12
|
55.211
USD
|
|
2023-09-29 |
2023-09-27 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
11.257
-0.7%
24,47
275.459
USD
|
11.257
-0.7%
|
24,47
|
275.459
USD
|
|
2023-09-27 |
2023-09-26 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
2.203
-2.0%
24,46
53.890
USD
|
2.203
-2.0%
|
24,46
|
53.890
USD
|
|
2023-09-27 |
2023-09-26 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
1.114
-1.0%
23,51
26.195
USD
|
1.114
-1.0%
|
23,51
|
26.195
USD
|
|
2023-09-27 |
2023-09-26 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
1.883
-1.7%
22,54
42.442
USD
|
1.883
-1.7%
|
22,54
|
42.442
USD
|
|
2023-09-27 |
2023-09-26 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
9.600
-0.6%
24,51
235.296
USD
|
9.600
-0.6%
|
24,51
|
235.296
USD
|
|
2023-09-27 |
2023-09-26 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
12.740
-0.8%
24,03
306.142
USD
|
12.740
-0.8%
|
24,03
|
306.142
USD
|
|
2023-09-27 |
2023-09-26 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
7.465
-0.5%
22,47
167.739
USD
|
7.465
-0.5%
|
22,47
|
167.739
USD
|
|
2023-09-27 |
2023-09-25 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
1.100
-0.1%
27,81
30.591
USD
|
1.100
-0.1%
|
27,81
|
30.591
USD
|
|
2023-09-27 |
2023-09-25 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
1.900
-0.1%
26,60
50.540
USD
|
1.900
-0.1%
|
26,60
|
50.540
USD
|
|
2023-09-27 |
2023-09-25 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
5.511
-0.4%
25,75
141.908
USD
|
5.511
-0.4%
|
25,75
|
141.908
USD
|
|
2023-09-27 |
2023-09-25 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
3.947
-0.3%
24,82
97.965
USD
|
3.947
-0.3%
|
24,82
|
97.965
USD
|
|
2023-09-25 |
2023-09-22 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
4.621
-0.3%
27,76
128.270
USD
|
4.621
-0.3%
|
27,76
|
128.270
USD
|
|
2023-09-25 |
2023-09-22 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
4.421
-0.3%
26,88
118.853
USD
|
4.421
-0.3%
|
26,88
|
118.853
USD
|
|
2023-09-25 |
2023-09-21 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
4.678
-0.3%
28,82
134.815
USD
|
4.678
-0.3%
|
28,82
|
134.815
USD
|
|
2023-09-25 |
2023-09-21 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
2.871
-0.2%
27,89
80.063
USD
|
2.871
-0.2%
|
27,89
|
80.063
USD
|
|
2023-09-21 |
2023-09-20 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
6.000
-5.4%
27,96
167.786
USD
|
6.000
-5.4%
|
27,96
|
167.786
USD
|
|
2023-09-21 |
2023-09-20 |
GV
Geplanter Verkauf
|
Ryder Sean
General Counsel
Führungsperson
|
10.000
-94.6%
30,00
300.000
USD
|
10.000
-94.6%
|
30,00
|
300.000
USD
|
|
2023-09-20 |
2023-09-19 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
8.247
-100.0%
27,16
223.979
USD
|
8.247
-100.0%
|
27,16
|
223.979
USD
|
|
2023-09-20 |
2023-09-19 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
23.920
-74.4%
26,21
626.962
USD
|
23.920
-74.4%
|
26,21
|
626.962
USD
|
|
2023-09-20 |
2023-09-18 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
2.927
-36.9%
24,17
70.754
USD
|
2.927
-36.9%
|
24,17
|
70.754
USD
|
|
2023-09-20 |
2023-09-18 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
27.365
-77.5%
23,20
634.895
USD
|
27.365
-77.5%
|
23,20
|
634.895
USD
|
|
2023-09-18 |
2023-09-18 |
GV
Geplanter Verkauf
|
Thomas John
Nicht geschäftsführender Verwaltungsratsmitglied
|
3.334
-0.7%
24,99
83.317
USD
|
3.334
-0.7%
|
24,99
|
83.317
USD
|
|
2023-09-18 |
2023-09-15 |
GV
Geplanter Verkauf
|
Thomas John
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.088
-0.2%
22,38
24.354
USD
|
1.088
-0.2%
|
22,38
|
24.354
USD
|
|
2023-09-18 |
2023-09-15 |
GV
Geplanter Verkauf
|
Thomas John
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.245
-0.5%
21,67
48.642
USD
|
2.245
-0.5%
|
21,67
|
48.642
USD
|
|
2023-09-18 |
2023-09-15 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
4.675
-4.2%
22,29
104.212
USD
|
4.675
-4.2%
|
22,29
|
104.212
USD
|
|
2023-09-18 |
2023-09-15 |
GV
Geplanter Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
5.725
-4.9%
21,56
123.418
USD
|
5.725
-4.9%
|
21,56
|
123.418
USD
|
|
2023-09-15 |
2023-09-14 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
13.871
-28.2%
22,31
309.522
USD
|
13.871
-28.2%
|
22,31
|
309.522
USD
|
|
2023-09-15 |
2023-09-14 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
11.405
-18.8%
21,77
248.285
USD
|
11.405
-18.8%
|
21,77
|
248.285
USD
|
|
2023-09-15 |
2023-09-13 |
V
Verkauf
|
Yu Yong
VP, Clinical Trial Operations
Führungsperson
|
29.800
-21.9%
21,14
629.927
USD
|
29.800
-21.9%
|
21,14
|
629.927
USD
|
|
2023-09-15 |
2023-09-13 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
3.315
-5.2%
22,31
73.961
USD
|
3.315
-5.2%
|
22,31
|
73.961
USD
|
|
2023-09-15 |
2023-09-13 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
15.717
-19.7%
21,26
334.132
USD
|
15.717
-19.7%
|
21,26
|
334.132
USD
|
|
2023-09-14 |
2023-09-13 |
V
Verkauf
|
Smither John W
Nicht geschäftsführender Verwaltungsratsmitglied
|
900
-11.5%
20,78
18.702
USD
|
900
-11.5%
|
20,78
|
18.702
USD
|
|
2023-09-13 |
2023-09-12 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
13.727
-14.7%
22,51
308.936
USD
|
13.727
-14.7%
|
22,51
|
308.936
USD
|
|
2023-09-13 |
2023-09-12 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
6.538
-6.5%
21,75
142.231
USD
|
6.538
-6.5%
|
21,75
|
142.231
USD
|
|
2023-09-13 |
2023-09-11 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
23.020
-18.7%
22,55
519.156
USD
|
23.020
-18.7%
|
22,55
|
519.156
USD
|
|
2023-09-13 |
2023-09-11 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
9.331
-7.1%
21,39
199.545
USD
|
9.331
-7.1%
|
21,39
|
199.545
USD
|
|
2023-09-11 |
2023-09-08 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
2.636
-2.0%
24,19
63.752
USD
|
2.636
-2.0%
|
24,19
|
63.752
USD
|
|
2023-09-11 |
2023-09-08 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
8.523
-5.9%
23,49
200.169
USD
|
8.523
-5.9%
|
23,49
|
200.169
USD
|
|
2023-09-11 |
2023-09-08 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
13.672
-8.7%
22,78
311.411
USD
|
13.672
-8.7%
|
22,78
|
311.411
USD
|
|
2023-09-11 |
2023-09-07 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
2.508
-1.6%
25,34
63.551
USD
|
2.508
-1.6%
|
25,34
|
63.551
USD
|
|
2023-09-11 |
2023-09-07 |
V
Verkauf
|
Szalay Aladar
Large shareholder
|
9.938
-5.9%
24,12
239.716
USD
|
9.938
-5.9%
|
24,12
|
239.716
USD
|
|